Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K E Edwards

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
BMC Cancer|October 18, 2013
N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myelomaShanique K E Edwards, Carissa R Moore, Yan Liu, et al.
Journal of Hematology & Oncology|September 10, 2014
Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytesShanique K E Edwards, Jacqueline Baron, Carissa R Moore, et al.
Scientific Reports|October 15, 2020
Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23Patrick L Mulcrone, Shanique K E Edwards, Daniela N Petrusca, et al.
Pediatrics|September 1, 1978
Enterobacter aerogenes primary bacteremia in pediatric patientsK E Edwards, J R Allen, M J Miller, et al.
Leukemia Research|January 8, 2016
Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cellsShanique K E Edwards, Yeming Han, Yingying Liu, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
BMC Cancer|October 18, 2013
N-benzyladriamycin-14-valerate (AD 198) exhibits potent anti-tumor activity on TRAF3-deficient mouse B lymphoma and human multiple myelomaShanique K E Edwards, Carissa R Moore, Yan Liu, et al.
Journal of Hematology & Oncology|September 10, 2014
Mutated in colorectal cancer (MCC) is a novel oncogene in B lymphocytesShanique K E Edwards, Jacqueline Baron, Carissa R Moore, et al.
Scientific Reports|October 15, 2020
Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23Patrick L Mulcrone, Shanique K E Edwards, Daniela N Petrusca, et al.
Pediatrics|September 1, 1978
Enterobacter aerogenes primary bacteremia in pediatric patientsK E Edwards, J R Allen, M J Miller, et al.
Leukemia Research|January 8, 2016
Signaling mechanisms of bortezomib in TRAF3-deficient mouse B lymphoma and human multiple myeloma cellsShanique K E Edwards, Yeming Han, Yingying Liu, et al.
Pageof 2